Nerva (XNV): Does it Score Well on Long-Term Trading Metrics Tuesday?

Tuesday, February 15, 2022 11:01 AM | InvestorsObserver Analysts

Nerva receives an average long-term technical score of 48 from InvestorsObserver's research based on historical trading patterns. The proprietary scoring system weighs price movement from recent months to a year, analyzes the coin's support and resistance levels, and where it is relative to long-term averages to determine whether it's a strong buy-and-hold investment opportunity. XNV currently holds a superior long-term technical analysis score than 48% of cryptos in circulation. This ranking metric is most useful to buy-and-hold type investors looking for strong steady growth when allocating their assets. coins with a high long and short-term technical score can help indicate assets that have bottomed out, providing investors a chance to 'buy the dip'.

InvestorsObserver is giving Nerva a 48 Long-Term Technical Rank. Find out what this means to you and get the rest of the rankings on Nerva!

See Full Report

Trading Analysis

XNV is currently -$0.0133137 (-50.07%) below its 100-day moving average price of $0.026587775 with its current price of $0.013274103. Meanwhile, Nerva is $0.0068869 (-172012.40%) above its 52-week low price of $0.006387171 and -$0.21794285 (-4319.20%) below its 52-week high of $0.231216952. The current price relative to its moving average and 52-week high and low leads to an average long-term technical score of 48. Trends for the long-term trading history of Nerva suggest that traders are currently bearish on the coin. Nerva has a total market value of $225,895.01 with an low average daily volume of $5,636.02 worth of the currency exchanged over a typical 24 hour period. As of the past 24 hours, XNV's volume is below its average with $874.11 exchanged in total.

Summary

XNV's historical trading over the past year gives it a an average long-term technical score of 48 as its price movement in that time has given investors reason to be bearish on the coin in the long-term. Click Here to get the full Report on Nerva (XNV).